Canadian Journal of Applied Sciences

ISSN: 1925-7430
Short Key Title: Can J App Sci
Start Year: 2011

Muhammad Wasim, Taseer Ahmad, Aftab Ullah
1. Riphah Institute of pharmaceutical sciences, Riphah International University, Islamabad, Pakistan. 2. Shifa College of Pharmaceutical Sciences, STMU, Islamabad, Pakistan. 3. Institute of Pharmaceutical Sciences, COMSAT Institute of Information Technology, Abbottabad, Pakistan.
Keywords: Role of Pharmacist, Case histories, HMC, Ward level.

The aim of this study was to evaluate case histories of patients admitted and also to highlight the role of pharmacist at ward level in Hayat Abad Medical Complex (HMC), Peshawar. A standard questionnaire was designed and thirty case histories of different diseases in medical ward were collected. The percentage incidence of different diseases like, diabetes mellitus (6.7%), respiratory tract infection (13.3%), chronic obstructive pulmonary disease (COPD) (16.6%) and hypertension (6.7%) were documented, in which percentage incidence of malaria (16.7%) was higher from the rest of diseases. The drugs which have observed for numerous drug interactions were steroidal drugs, warfarin, PPIs, benzodiazepines, NSAIDs, furosemide and anti T.B drugs. The most frequently recorded intervention was additive type (80%). In order to eliminate such undesired accomplishments clinical pharmacist services must be brought at ward level in health care system.

Article Information

Identifiers and Pagination:
First Page:33
Last Page:39
Publisher Id:CanJAppSci (2014 ). 4. 33-39
Article History:
Received:November 7, 2013
Accepted:December 19, 2013
Collection year:2013
First Published:January 1, 2014

© 2016 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license. You are free to: Share — copy and redistribute the material in any medium or format Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. No additional restrictions You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
Editor in Chief
Xianghui Qi (PhD)
Jiangsu University, Zhenjiang, China


Dr. Xianghui Qi is working as Professor in the School of Food & Biological Engineering, Jiangsu University, China. His research interests: Biosynthesis of high value-added chemicals by microbes and engineered strains; Discovery of novel genes, enzymes and new strains; Rational & Irrational design of microbial enzymes; Isolation, identification and evolution of microbes; Metabolic engineering & Pathway engineering of functional microbes, and biotransformation; Metabolic regulation based on the research of microbial omics; Application of high value-added products including functional sugar alcohols by biosynthesis and biotransformation based on microbial engineered strains.

Journal Highlights
Abbreviation: Can J Appl Sci
Frequency: Annual
Current Volume: 7 (2017)
Next scheduled volume: December, 2018  
Back volumes: 1-7
Starting year: 2011
Nature: Online
Submission: Online
Language: English

Subject & Scope
  • Biochemistry and Biotechnology
  • Bioinformatics and Biometric
  • Chemical Technology
  • Dentistry and Hygiene
  • Environmental Health, Safety and Allied Sciences
  • Food and Nutrition
  • Health Management
  • Medical Sciences
  • Molecular/ Cellular Biology
  • Pharmaceutical Sciences
  • Pharmacotherapy
  • Theoretical Models (health, life and clinical practice)
  • Veterinary, Fishery and Animal Biology

Consortium Publisher is an online publisher that enjoys global presence with International Journals

Follow Us

©2009 - 2019 Consortium Publisher Canada

Contact Info

6252 Lisgar Dr Mississauga Ontario L5N7V2 Canada
+1 (647) 526-0885